ElevateBio Funding & Investors
Cambridge, MA
ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.
elevate.bioTotal Amount Raised: $1,246,000,000
ElevateBio Funding Rounds
Series D
$401,000,000
Series D Investors
Matrix Capital ManagementRedmile GroupMPM CapitalSoftBank Vision FundF2 VenturesWoodline PartnersInvusNovo NordiskFidelity InvestmentsEmerson CollectiveSurveyor CapitalEcoR1 CapitalSamsara BioCapitalVertex HoldingsEDBIITOCHULee Family OfficeSeries C
$525,000,000
Series C Investors
Matrix Capital ManagementEcoR1 CapitalMPM CapitalSoftBank Vision FundF2 VenturesInvusFidelity InvestmentsVertex HoldingsRedmile GroupITOCHUSurveyor CapitalSamsara BioCapitalEmerson CollectiveEDBISeries B
$170,000,000
Series B Investors
EDBISamsara BioCapitalInvusF2 VenturesRedmile GroupMPM CapitalEcoR1 CapitalVertex HoldingsSurveyor CapitalSeries A
$150,000,000
Series A Investors
UBS Oncology Impact FundRedmile GroupSamsara BioCapitalEcoR1 Capital
Funding info provided by Diffbot.